.png)
Cardiovascular disease remains Australia's leading cause of death, yet screening rates are low and public awareness is shaped by outdated stereotypes. CardiAction needed a brand and growth strategy that could shift cultural perception while building a viable pharmacy-based screening network.
The preventative health market in Australia is growing but fragmented. Pharmacy-based health services are expanding as consumers seek accessible alternatives to traditional GP pathways. CardiAction's opportunity was to own the screening category before larger players moved in.
We built a brand for clinical trust and consumer action. One identity that earns credibility with pharmacists and GPs, and cuts through with the public, so it works in a clinic and in a social feed.
Antimony delivered brand strategy, content architecture, digital marketing and a pharmacy partnership program. The brand needed to speak two languages at once: clinical credibility for healthcare partners, and accessible urgency for the public.
The B2B strategy positioned CardiAction as a trusted partner for pharmacies, with a structured onboarding program and co-branded marketing assets. The system made it easy for pharmacy teams to integrate screening into their existing service model, growing the network to 72 active pharmacy locations and 200+ screenings booked every week.
Beyond the commercial model, the content strategy addressed cultural barriers to cardiovascular screening. Antimony produced 120+ paid and organic assets weekly across Meta, reframing heart health as relevant for all ages, genders and backgrounds.
The work drove a 320% increase in cardiovascular screening enquiries, a 44% reduction in cost-per-booking and a 4.8x return on ad spend.
